What did the within-trial cost-utility analysis of the PREFER trial by Brannstrom et al. 2014 find?
The within-trial cost-utility analysis of the PREFER trial by Brannstrom et al. 2014 found that this multidisciplinary approach (MDT) is more effective and less costly than usual care, and therefore dominated (more effective, less costly) usual care. This study suggests that an MDT is likely to be cost saving compared to usual care.